Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT) A Phase 3 Randomized Controlled Trial Presented in part at: Retina Day, American Academy of Ophthalmology Annual Meeting, November 2015, Las Vegas, Nevada.

Ophthalmology

Volumn 123, Issue 6, 2016, Pages 1287-1296

  Jackson, Timothy L ^a,b   Desai, Riti ^b   Simpson, Andrew ^a,b   Neffendorf, James E ^a,b   Petrarca, Robert ^a,b   Smith, Kelly ^c   Wittes, Janet ^c   Lewis, Cornelius ^a,b   Membrey, Luke ^d   Haynes, Richard ^e   Costen, Mark ^f   Steel, David H W ^g,i   Muldrew, Alyson ^h   Chakravarthy, Usha ^h  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c University of Iowa   (United States)

^d MAIDSTONE HOSPITAL   (United Kingdom)

^e BRISTOL EYE HOSPITAL   (United Kingdom)

^f HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^g SUNDERLAND EYE INFIRMARY   (United Kingdom)

^h QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; STRONTIUM; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGE RELATED MACULAR DEGENERATION; AGED; BLURRED VISION; BRACHYTHERAPY; CATARACT; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOPHTHALMITIS; EPIMACULAR BRACHYTHERAPY; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; NEOVASCULAR AGE RELATED MACULAR DEGENERATION; OPTICAL COHERENCE TOMOGRAPHY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION; UVEITIS; VISUAL ACUITY; VISUAL ACUITY REDUCTION; VISUAL DISORDER; VITRECTOMY; VITREOUS FLOATERS; VITREOUS HEMORRHAGE; ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; CHRONIC DISEASE; CLINICAL TRIAL; FEMALE; INTRAVITREAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RADIATION INJURIES; RADIATION RESPONSE; RETINA; RETINA MACULA LUTEA; SALVAGE THERAPY; VERY ELDERLY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BRACHYTHERAPY; CHRONIC DISEASE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MALE; MIDDLE AGED; RADIATION INJURIES; RANIBIZUMAB; RETINA; SALVAGE THERAPY; STRONTIUM RADIOISOTOPES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRECTOMY; WET MACULAR DEGENERATION;

EID: 84964323865     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.02.028     Document Type: Conference Paper

References (21)

1. M.P. Avila, M.E. Farah, A. Santos, and et al. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration Br J Ophthalmol 93 2009 305 309
2. U. Chakravarthy, T.A. Gardiner, D.B. Archer, and C.J. Maguire A light microscopic and autoradiographic study of non-irradiated and irradiated ocular wounds Curr Eye Res 8 1989 337 348
3. J.F. Kirwan, P.H. Constable, I.E. Murdoch, and P.T. Khaw Beta irradiation: new uses for an old treatment: a review Eye (Lond) 17 2003 207 215
4. R.F. Spaide Rationale for combination therapy in age-related macular degeneration Retina 29 6 Suppl 2009 S5 S7
5. R. Petrarca, M. Richardson, A. Douiri, and et al. Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results Retina 33 2013 1232 1240
6. P.U. Dugel, J.D. Bebchuk, J. Nau, and et al. Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET) Ophthalmology 120 2013 317 327
7. Jackson TL, Dugel PU, Bebchuk JD, et al. Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): fluorescein angiography and optical coherence tomography. Ophthalmology 2013;120:1597-603.
8. D.F. Martin, M.G. Maguire, S.L. Fine, and et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 2012 1388 1398
9. P.U. Dugel, R. Petrarca, M. Bennett, and et al. Macular epiretinal brachytherapy in treated age-related macular degeneration: MERITAGE study: twelve-month safety and efficacy results Ophthalmology 119 2012 1425 1431
10. R. Petrarca, P.U. Dugel, J. Nau, and et al. Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 12 optical coherence tomography and fluorescein angiography Ophthalmology 120 2013 328 333
11. T.L. Jackson, P.U. Dugel, J.D. Bebchuk, and et al. Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): fluorescein angiography and optical coherence tomography Ophthalmology 120 2013 1597 1603
12. G.A. Lalwani, P.J. Rosenfeld, A.E. Fung, and et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO study Am J Ophthalmol 148 2009 43 58 e1
13. A.E. Fung, G.A. Lalwani, P.J. Rosenfeld, and et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration Am J Ophthalmol 143 2007 566 583
14. F.G. Holz, W. Amoaku, J. Donate, and et al. Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study Ophthalmology 118 2011 663 671
15. Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity Ophthalmology 121 2014 1092 1101
16. T.L. Jackson, U. Chakravarthy, P.K. Kaiser, and et al. Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study Ophthalmology 120 2013 1893 1900
17. H.S. Chin, T.S. Park, Y.S. Moon, and J.H. Oh Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes Retina 25 2005 556 560
18. J.B. Christoforidis, Z. Xie, A. Jiang, and et al. Serum levels of intravitreal bevacizumab after vitrectomy, lensectomy and non-surgical controls Curr Eye Res 38 2013 761 766
19. M. Kakinoki, O. Sawada, T. Sawada, and et al. Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys Invest Ophthalmol Vis Sci 53 2012 5877 5880
20. R. Petrarca, and T.L. Jackson Radiation therapy for neovascular age-related macular degeneration Clin Ophthalmol 5 2011 57 63
21. T.L. Jackson, P.H. Donachie, J.M. Sparrow, and R.L. Johnston United Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery: report 1; case mix, complications, and cataract Eye (Lond) 27 2013 644 651